January 08, 2008
The board of directors of Draxis Health has appointed Dan Brazier as president and CEO effective Jan. 1. In addition, the board has also appointed Jean-Pierre Robert to the position of COO of Draxis Health. Robert will also continue to retain his position as President of Draxis Specialty Pharmaceuticals, the company's whollyowned operating subsidiary. These new appointments are the result of a long-term process established by the company to identify a successor to Dr. Martin Barkin, who retired as president and CEO and resigned from the board of directors Dec. 31, 2007.